These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 405730)

  • 41. Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis.
    Dixon JS; Pickup ME; Bird HA; Lee MR; Wright V; Downie WW
    Ann Rheum Dis; 1981 Oct; 40(5):480-8. PubMed ID: 6796009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of rheumatoid arthritis with gold salts].
    Aranguena L; Hinojosa W; Chincaro C; Portugal J; Barrenechea O
    Rev Clin Esp; 1984 Jun 15-30; 173(5-6):305-8. PubMed ID: 6238373
    [No Abstract]   [Full Text] [Related]  

  • 43. Gold sodium thiomalate for the treatment of rheumatoid arthritis in a patient with hepatitis B.
    Buckley WA; Stump AL; Monger RM; Lookabill SK
    Ann Pharmacother; 2011 Apr; 45(4):e23. PubMed ID: 21467262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of penicillamine and gold treatment in early rheumatoid arthritis.
    Mäkisara P; Nissilä M; Kajander A; Martio J; von Essen R; Anttila P; Mäkisara GL
    Scand J Rheumatol; 1978; 7(3):166-70. PubMed ID: 103190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
    Capell HA; Lewis D; Carey J
    Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate.
    Rau R; Herborn G; Menninger H; Sangha O
    Br J Rheumatol; 1998 Nov; 37(11):1220-6. PubMed ID: 9851273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [HLA DR7 as a protective factor against gold salt toxicity in rheumatoid arthritis].
    Rodríguez Pérez M; González Domínguez J; Matarán Pérez L; Salvatierra Ríos D
    An Med Interna; 1993 Oct; 10(10):484-6. PubMed ID: 8136425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of cigarette smoking on blood gold distribution during chrysotherapy.
    James DW; Ludvigsen NW; Cleland LG; Milazzo SC
    J Rheumatol; 1982; 9(4):532-5. PubMed ID: 6813469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.
    Lawrence JS
    Ann Rheum Dis; 1976 Apr; 35(2):171-3. PubMed ID: 821403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vasomotor (nitritoid) reactions induced by sodium aurothiomalate and enap].
    Murav'ev IuV; Tsapina TN
    Ter Arkh; 2002; 74(5):79-80. PubMed ID: 12087916
    [No Abstract]   [Full Text] [Related]  

  • 52. Gold kinetics following aurothiomalate therapy: use of a whole-body radiation counter.
    Gerber RC; Paulus HE; Jennrich RI; Lederer M; Bluestone R; Blahd WH; Pearson CM
    J Lab Clin Med; 1974 May; 83(5):778-89. PubMed ID: 4207022
    [No Abstract]   [Full Text] [Related]  

  • 53. [Reactions against sodium-auro-thiomalate in the treatment of rheumatoid arthritis].
    Cruz Filho A; Gomes IJ; Budaruiche JS
    Z Rheumatol; 1979; 38(9-10):381-4. PubMed ID: 118603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions.
    Klinefelter
    J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum gold. II. Levels in rheumatoid arthritis.
    Rubinstein HM; Dietz AA
    Ann Rheum Dis; 1973 Mar; 32(2):128-32. PubMed ID: 4266407
    [No Abstract]   [Full Text] [Related]  

  • 56. One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo.
    Williams HJ; Dahl SL; Ward JR; Karg M; Willkens RF; Meenan RF; Altz-Smith M; Clegg DO; Mikkelsen WM; Kay DR
    Arthritis Rheum; 1988 Jan; 31(1):9-14. PubMed ID: 3125841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine.
    Palosuo T; Kajander A; von Essen R; Milgrom F
    Clin Immunol Immunopathol; 1978 Jul; 10(3):355-64. PubMed ID: 97039
    [No Abstract]   [Full Text] [Related]  

  • 58. Maintenance chrysotherapy in rheumatoid arthritis: a comparison of 2 dose schedules.
    Griffin AJ; Gibson T; Huston G; Taylor A
    Ann Rheum Dis; 1981 Jun; 40(3):250-3. PubMed ID: 6787995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of chrysotherapy on radiographical changes and on the optimal time of initiation of therapy.
    Luukkainen R
    Scand J Rheumatol Suppl; 1980; 34():1-56. PubMed ID: 6791272
    [No Abstract]   [Full Text] [Related]  

  • 60. Corneal chrysiasis and clinical improvement with chrysotherapy in rheumatoid arthritis.
    Prouse PJ; Kanski JJ; Gumpel JM
    Ann Rheum Dis; 1981 Dec; 40(6):564-6. PubMed ID: 6800311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.